Trending
April 22, 2024

KalVista Pharmaceuticals Appoints William C. Fairey to Board of Directors

April 19, 2024

TScan Therapeutics Closes of Upsized Public Offering

April 18, 2024

Verastem Oncology Appoints John Hayslip, M.D., to Chief Medical Officer

April 18, 2024

Biohaven Prices of $230 Million Public Offering of Common Shares

April 18, 2024

Provident Healthcare Partners Advises Community Eye Care Specialists in its Affiliation with EyeSouth Partners

April 18, 2024

Pathios Therapeutics Raises $25M in Series B

April 18, 2024

Korro Announces $70 Million Private Placement

April 18, 2024

Morphoceuticals Appoints Jim Jenson, PhD as CEO

April 17, 2024

Sensorium Therapeutics Appoints Sam Rasty as Chief Business Officer

April 17, 2024

Xeno Biosciences Appoints Dennis Kim CEO

April 17, 2024

Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer

April 17, 2024

Domain Therapeutics Appoints Sean A. MacDonald as Chief Executive Officer

April 17, 2024

Javelin Biotech Appoints Jacques Banchereau, PhD as Chief Scientific Officer

April 17, 2024

TScan Therapeutics Prices of Upsized $150 Million Public Offering

April 16, 2024

Barton Healthcare Staffing Appoints Anne Zukowski as Executive Vice President

April 16, 2024

VBI Vaccines Reports Full Year 2023 Financial Results